ABOUT US

The 4th Innovation Forum in In Vitro Diagnostics is an initiative promoted by the Spanish Federation of Health Technology Companies in collaboration with the Spanish Platform for Innovation in Healthcare and Medical Devices Technologies.

Aim of the entities acting as Promoters of this Forum is to facilitate the arrival to markets of those projects with the highest added value, coming from entrepreneurs, RTD centers, institutions or SMEs, through collaboration agreements, investment or co-investment with the promoting entities.

The projects promoted by this Forum will be exclusively those related to the field of In Vitro Diagnostics

In this 4th Forum of Entrepreneurs in In Vitro Diagnostics, the participating industrial promoter partners are IZASA, LETI, PALEX, ROCHE, VIRCELL, and VITRO and the VC entities CAIXA CAPITAL RISK, CRB INVERBIO, HEALTHEQUITY and YSIOS CAPITAL PARTNERS.

Additionally, the promoters will give preference to those projects that meet some of the following characteristics:

  • Contributes as a novelty or very relevant advance in the "state of the art" of a diagnosis and / or the technologies currently available. At least a very substantial improvement for the user or the patient will be required.

  • Project is in a phase of development sufficiently advanced to be able to commercially dispose of the product / service in a period of time not exceeding two / three years. TRL6 and forward though TRL5 might be consider

  • Entrepreneurs should justify by providing relevant info regarding market and competition that endorse, on the one hand, the need that he / she intends to cover and on the other hand, the economic viability and the business model to be successfully taken to the market.

  • Availability and openness to negotiate, different types of agreements with any of the promoters, provided they can be considered beneficial by all parties.

  • Otherwise, it would be desirable for the entrepreneur to detail the restrictions or limitations to which he is subject.